First-step use of fixed-dose combination treatment in stage 2 hypertensive patients: has the time come?

Journal of clinical hypertension (Greenwich, Conn.)

Volumn 9, Issue 4, 2007, Pages 276-284

  Weber, Michael A ^a   Ruilope, Luis ^a   Giles, Thomas D ^a   Izzo Jr , Joseph L ^a  

^a Downstate Health Sciences University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BLOOD PRESSURE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; HUMANS; HYPERTENSION;

EID: 34547668998     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2007.06659.x     Document Type: Conference Paper

References (0)